Experienced in Nevoid Basal Cell Carcinoma Syndrome

Dr. Jeffrey B. Travers

Wright State Physicians, Inc.

Fairborn, OH

Experienced

in Nevoid Basal Cell Carcinoma Syndrome

Specialties:Dermatology

Accepting New Patients

OverviewInsuranceLocationsClinical Research

Overview

Jeffrey Travers is a Dermatologist in Fairborn, Ohio. Dr. Travers and is rated as an Experienced provider by MediFind in the treatment of Nevoid Basal Cell Carcinoma Syndrome. His top areas of expertise are Actinic Keratosis, Atopic Dermatitis, Melanoma, Psoriasis, and Vertebroplasty. Dr. Travers is currently accepting new patients.

His clinical research consists of co-authoring 140 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Nevoid Basal Cell Carcinoma Syndrome.

Specialties

Dermatology

Licenses

Dermatology in OH

Languages Spoken

English

Spanish

Gender

Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

Anthem
UnitedHealthcare
CareSource
Humana

Locations

Wright State Physicians, Inc.
725 University Blvd., Fairborn, OH 45324

937-245-7200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)

Enrollment Status: Withdrawn

Publish Date: February 08, 2024

Intervention Type: Other, Drug

Study Drug: Nomacopan

Study Phase: Phase 3

A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Enrollment Status: Terminated

Publish Date: September 18, 2023

Intervention Type: Drug

Study Phase: Phase 2

A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Enrollment Status: Completed

Publish Date: July 03, 2023

Intervention Type: Drug

Study Phase: Phase 2

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

Enrollment Status: Terminated

Publish Date: March 21, 2023

Intervention Type: Drug

Study Drug: Mirikizumab

Study Phase: Phase 3

A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Enrollment Status: Terminated

Publish Date: November 08, 2022

Intervention Type: Drug

Study Drug: Baricitnib

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Enrollment Status: Completed

Publish Date: September 09, 2022

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis

Enrollment Status: Completed

Publish Date: October 06, 2021

Intervention Type: Drug

Study Drug: LY3454738

Study Phase: Phase 1

Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis

Enrollment Status: Completed

Publish Date: September 27, 2021

Intervention Type: Drug

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2

Enrollment Status: Completed

Publish Date: March 30, 2021

Intervention Type: Drug

Study Phase: Phase 3

A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis

Enrollment Status: Completed

Publish Date: July 28, 2020

Intervention Type: Drug

Study Phase: Phase 4

View 9 Less Clinical Trials

139 Total Publications

A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs.

Journal: The Journal of dermatological treatment

Published: September 15, 2024

View All 139 Publications

Similar Doctors

Expertise in

conditions

Dr. Radhika N. Nakrani

Dermatology

Expertise in

conditions

Dr. Radhika N. Nakrani

Dermatology

Dermatologists Of Southwest Ohio - Riverside

3555 Olentangy River Road, Suite 4000,

Columbus, OH

(56.5 mi)

614-268-2748

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Radhika Nakrani is a Dermatologist in Columbus, Ohio. Dr. Nakrani and is rated as an Advanced provider by MediFind in the treatment of Nevoid Basal Cell Carcinoma Syndrome. Her top areas of expertise are Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Nakrani is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition

View All 17 Experienced Conditions

Want to save this doctor for later?

Looking for the best doctor for you?

Start Here

Is this your doctor?

Find A Second Opinion

Not sure about your diagnosis?

Check Your Symptoms

Learn about our expert tiers

Learn More

Are you the provider on this profile?

Claim Profile